Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2022 02:00 ET | Source: Xinvento BV

Dutch biotech Xinvento raises seed round to develop a treatment for the rare disease Congenital Hyperinsulinism

AMSTERDAM, April 21, 2022 (GLOBE NEWSWIRE) -- Xinvento, a biotech company aiming to improve the lives of those with Congenital Hyperinsulinism, announces today the completion of a seed funding...
April 20, 2022 10:03 ET | Source: NatureServe

The NatureServe Network Van Tour is Documenting At-Risk Plants and Animals Near You

Washington, DC, April 20, 2022 (GLOBE NEWSWIRE) -- For nearly 50 years, NatureServe has been the authoritative source for biodiversity data throughout North America. This Earth Month its President...
April 19, 2022 09:10 ET | Source: BioSig Technologies, Inc.

BioSig to Present at Heart Rhythm 2022

Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
April 19, 2022 08:00 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics to Report First Quarter 2022 Results and Announces Participation at Upcoming Investor Conferences

WATERTOWN, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel...
April 14, 2022 11:30 ET | Source: Slalom

Slalom expansion continues with new market opening in Kansas City

KANSAS CITY, Mo., April 14, 2022 (GLOBE NEWSWIRE) -- Slalom, a global consulting firm focused on strategy, technology, and business transformation, today announced its newest market opening in...
April 14, 2022 11:10 ET | Source: NatureServe

Iconic Wildflowers in Peril: New Report Highlights Threats to Trillium in North America

Washington, DC, April 14, 2022 (GLOBE NEWSWIRE) -- Among North American wildflowers, few are as beloved and culturally relevant as Trillium. A new report led by the ABQ BioPark, NatureServe, and Mt....
April 11, 2022 13:15 ET | Source: Slalom

Slalom named a 2022 Fortune® 100 Best Companies to Work For®

SEATTLE, April 11, 2022 (GLOBE NEWSWIRE) -- Slalom, a global consulting firm that helps people and organizations dream bigger, move faster, and build better tomorrows for all, has been recognized by...
April 08, 2022 13:02 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Presents Preclinical Data Highlighting Biological Superiority of MDM2 Degradation over Inhibition and Shares Profile of Clinical Candidate KT-253 at the American Association for Cancer Research (AACR) Annual Meeting 2022

MDM2 degradation demonstrated differentiated biological activity and superior cell killing compared to small molecule inhibition in p53 wild-type tumors and led to tumor regressions in xenograft...
April 07, 2022 08:30 ET | Source: BioSig Technologies, Inc.

BioSig to Present at NobleCon18 Capital Markets Conference

Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
April 06, 2022 12:55 ET | Source: Education Next

Fewer scientists, more skepticism of science in states that limit evolution instruction

Cambridge, Massachusetts, April 06, 2022 (GLOBE NEWSWIRE) -- State science standards meaningfully affect student learning, adult attitudes about science, and future career choices, Benjamin W. Arold...